Abstract
Background COVID-19 has had large impact on care-home residents internationally. This study systematically examines care-home outbreaks of COVID-19 in a large Scottish health board.
Methods Analysis of testing, cases and deaths using linked care-home, testing and mortality data for 189 care-homes with 5843 beds in a large Scottish Health Board up to 15/06/20.
Findings 70 (37.0%) of care-homes experienced a COVID-19 outbreak, 66 of which were in care-homes for older people where care-home size was strongly associated with outbreaks (OR per 20-bed increase 3.50, 95%CI 2.06 to 5.94). There were 852 confirmed cases and 419 COVID-related deaths, 401 (95.7%) of which occurred in care-homes with an outbreak, 16 (3.8%) in hospital, and two in the 119 care-homes without a known outbreak. For non-COVID related deaths, there were 73 excess deaths in care-homes with an outbreak, but no excess deaths in care-homes without an outbreak, and 24 fewer deaths than expected of care-home residents in hospital. A quarter of COVID-19 related cases and deaths occurred in five (2.6%) care-homes, and half in 13 (6.9%) care-homes.
Interpretation The large impact on excess deaths appears to be primarily a direct effect of COVID-19, with cases and deaths are concentrated in a minority of care homes. A key implication is that there is a large pool of susceptible residents if community COVID-19 incidence increases again. Shielding residents from potential sources of infection and rapid action into minimise outbreak size where infection is introduced will be critical in any wave 2.
Funding Not externally funded.
Research in context
Evidence before this study
We searched PubMed and the medRxiv preprint server using terms ‘long-term care’, ‘nursing home’, ‘care home’, or ‘residential care’ combined with ‘COVID-19’ and/or ‘SARS-CoV-2’, updated to 25th June. The existing published literature highlights the large impact in care-homes, and that atypical disease presentation, asymptomatic carriage and a presymptomatic infectious period is common in both residents and staff. One living systematic review confirms the international outbreak burden among residents and staff and high but varied international mortality rates. International modelling studies have failed to take account of the care-home environment and context, making estimates informed by general community transmission of infection. Only one peer-reviewed study was identified which evaluated US nursing home characteristics associated with outbreaks, finding associations with larger facility size, urban location, and ethnicity, but no association with quality ratings or ownership.
Added value of this study
This study reports data for all 189 care homes in one large Scottish health board, where 37% experienced an outbreak of COVID-19, with 95% of outbreaks in care-homes for older people. The number of beds was the only care-home characteristic statistically significantly associated with the presence of an outbreak. One-third of affected care homes had only single cases or short outbreaks, but sustained outbreaks were common, and there was evidence of potential reintroduction of infection in some care-homes with >14 day gaps between confirmed cases. Cases and mortality were heavily concentrated. In care-homes with an outbreak there were 472 excess deaths (12.3% of bed capacity, 3.1 times the average in the previous five years), 85% of which were COVID-19 related. There were only 16 COVID-19 related deaths and 14 other deaths of care-home residents in hospital in the same period, consistent with ∼20 non-COVID excess deaths occurring in care-homes being deaths that would have happened anyway. 99% of the excess deaths and of the COVID-19 related deaths were in care-homes with an outbreak, suggesting that quality and safety of care in the wider care system was not affected.
Implications of all the available evidence
Outbreak patterns varied considerably and more detailed understanding of why some care homes avoided or controlled outbreaks would allow learning to prepare for wave two. Systematic, regular testing and use of whole genome sequencing will inform understanding of transmission dynamics and future outbreak management. Future research should consider the built environment and organisation of care as other potentially modifiable factors to support infection control. Improving national and local data on the care-home population is a priority both for COVID-19 and for ensuring this vulnerable population receives better care in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The analysis was not externally funded.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Analysis was of public health data at care-home level (with no individual or identifiable patient data) in order to understand the evolution of COVID-19 outbreaks in one health board. Separate research ethics review was not required as this work was undertaken under generic approval for the Lothian Research Safe Haven and the NHS Lothian/University of Edinburgh Dataloch partnership agreement. Care Inspectorate data is publicly available at https://www.careinspectorate.com/index.php/statistics-and-analysis/data-and-analysis and is public sector information licensed under the Open Government Licence v3.0.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Jenni.Burton{at}glasgow.ac.uk, Gwen.Bayne{at}nhslothian.scot.nhs.uk, Christine.Evans{at}nhslothian.scot.nhs.uk, fgarbe{at}nhs.net, Dermot.Gorman{at}nhslothian.scot.nhs.uk, Naomi.Honhold{at}nhslothian.scot.nhs.uk, Duncan.McCormick{at}nhslothian.scot.nhs.uk, Richard.Othieno{at}nhslothian.scot.nhs.uk, Janet.Stevenson{at}nhslothian.scot.nhs.uk, Stefanie.Swietlik{at}nhslothian.scot.nhs.uk, kate.templeton{at}ed.ac.uk, mette.tranter{at}nhslothian.scot.nhs.uk, Lorna.Willocks{at}nhslothian.scot.nhs.uk, Bruce.Guthrie{at}ed.ac.uk
Data Availability
Data may be available on request to the corresponding author, subject to NHS Scotland disclosure controls to prevent identification of individuals.
